What is Lutetium Therapy?
Lutetium therapy, also known as Lutetium-177 therapy or Lutetium-177 dotatate therapy, is a targeted radionuclide therapy used for the treatment of certain types of neuroendocrine tumors, particularly those that express high levels of somatostatin receptors. It involves the administration of Lutetium-177, a radioactive isotope, combined with a somatostatin analog called dotatate, which binds to the somatostatin receptors on tumor cells. The radiation emitted by Lutetium-177 helps destroy the&
What is the Cost of Lutetium Therapy?
The cost of Lutetium Therapy is between Rs. 7,00,000 to Rs. 8,00,000 approximately.
Who is the Right Candidate for Lutetium Therapy?
Lutetium therapy is typically recommended for patients with advanced or metastatic neuroendocrine tumors, such as gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and neuroendocrine tumors of the lungs (bronchial carcinoids), that show high levels of somatostatin receptor expression. A thorough evaluation by an oncologist or nuclear medicine specialist is necessary to determine if a patient is a suitable candidate for Lutetium therapy.
Technology Used in Lutetium Therapy:
Lutetium therapy involves the utilization of advanced nuclear medicine technology, including:
- Radiopharmaceuticals: Lutetium-177 combined with dotatate is the radiopharmaceutical used in Lutetium therapy. The combination allows for targeted delivery of radiation to tumor cells that express somatostatin receptors.
- Molecular Imaging: Imaging techniques such as somatostatin receptor scintigraphy (SRS) or positron emission tomography (PET) scans using somatostatin analogs labeled with radioactive tracers help in the diagnosis, staging, and selection of appropriate patients for Lutetium therapy.
- Radiation Safety Measures: Proper radiation safety measures are implemented during the administration, handling, and disposal of Lutetium-177, ensuring the safety of healthcare professionals and minimizing radiation exposure to others.